Literature DB >> 23196710

Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.

Feng Ling Wang1, Li Qin Tang, Feng Yang, Ling Na Zhu, Ming Cai, Wei Wei.   

Abstract

Berberine (BBR), an effective compound of Chinese traditional herbal medicine, has preventive effects on diabetes and its complications. In this study, we investigated the therapeutic effects and underlying molecular mechanisms of BBR in rats with high-fat diet and streptozotocin (STZ)-induced diabetic nephropathy model. BBR (50, 100, 200 mg/kg/d) were orally administered to male Sprague-Dawley rats after STZ injection and conducted for 8 weeks. Renal damage was evaluated by kidney weight to body weight ratio (KW/BW), urine microalbumin (UMAlb), urine protein for 24 h (UP24 h), urine creatinine (UCr), and histological examination. Type IV collagen and transforming growth factor-beta1 (TGF-β1) were detected by immunohistochemistry and ultrastructure of glomeruli was observed. Fasting blood glucose (FBG),serum creatinine (SCr), blood urea nitrogen (BUN), total cholesterol (TC), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-c), low-density lipoprotein-cholesterol (LDL-c) in serum and G protein-coupled receptor kinases (GRKs), cAMP in kidney were measured. Remarkable renal damage, hyperglycemia and hyperlipidemia were observed in DN rats. BBR could restore renal functional parameters, suppress alterations in histological and ultrastructural changes in the kidney tissues, improve glucose and lipid metabolism disorders, and increase cAMP levels compared with those of DN model group. Furthermore, BBR down-regulated total protein expression of GRK2, GRK3 and up-regulated expression of GRK6 of renal cortex in DN rats, but had a slight effects on GRK4 and GRK5. These studies demonstrate, for the first time, that BBR exerts renoprotection in high-fat diet and STZ-induced DN rats by modulating the proteins expression of GRKs in G protein- AC-cAMP signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196710     DOI: 10.1007/s11033-012-2321-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  54 in total

Review 1.  Phosphorylation-independent attenuation of GPCR signalling.

Authors:  Stephen S G Ferguson
Journal:  Trends Pharmacol Sci       Date:  2007-03-09       Impact factor: 14.819

2.  Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway.

Authors:  Qin Jiang; Peiqing Liu; Xiaoqian Wu; Weihua Liu; Xiaoyan Shen; Tian Lan; Suowen Xu; Jing Peng; Xi Xie; Heqing Huang
Journal:  Mol Cell Endocrinol       Date:  2010-07-30       Impact factor: 4.102

3.  Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.

Authors:  Yanwen Wang; Tony Campbell; Benjamin Perry; Cécile Beaurepaire; Ling Qin
Journal:  Metabolism       Date:  2010-03-20       Impact factor: 8.694

4.  Kidney involvement in a nongenetic rat model of type 2 diabetes.

Authors:  Ratna S Danda; Nusrath M Habiba; Hernan Rincon-Choles; Basant K Bhandari; Jeffrey L Barnes; Hanna E Abboud; Pablo E Pergola
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

5.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Authors:  D Koya; M Haneda; H Nakagawa; K Isshiki; H Sato; S Maeda; T Sugimoto; H Yasuda; A Kashiwagi; D K Ways; G L King; R Kikkawa
Journal:  FASEB J       Date:  2000-03       Impact factor: 5.191

6.  Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition.

Authors:  Weihua Liu; Futian Tang; Yanhui Deng; Xuejuan Li; Tian Lan; Xiaoyan Zhang; Heqing Huang; Peiqing Liu
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

7.  Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism.

Authors:  Qian Zhang; Xinhua Xiao; Kai Feng; Tong Wang; Wenhui Li; Tao Yuan; Xiaofang Sun; Qi Sun; Hongding Xiang; Heng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-26       Impact factor: 2.629

Review 8.  TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy.

Authors:  Claire E Hills; Paul E Squires
Journal:  Am J Nephrol       Date:  2009-11-04       Impact factor: 3.754

Review 9.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

10.  Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.

Authors:  K Sharma; Y Jin; J Guo; F N Ziyadeh
Journal:  Diabetes       Date:  1996-04       Impact factor: 9.461

View more
  14 in total

1.  Preventive use of berberine in inhibition of lead-induced renal injury in rats.

Authors:  Parisa Hasanein; Hassan Riahi
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-04       Impact factor: 4.223

2.  Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy.

Authors:  Li Qin Tang; Sheng Liu; Shan Tang Zhang; Ling Na Zhu; Feng Ling Wang
Journal:  Mol Biol Rep       Date:  2014-02-01       Impact factor: 2.316

Review 3.  Modulatory effect of berberine on plasma lipoprotein (or lipid) profile: a review.

Authors:  Navid Nourizadeh; Leila Vazifeh Mostaan; Ehsan Saburi; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

4.  Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.

Authors:  Jian Gao; Zheng Liang; Fei Zhao; Xiaojing Liu; Ning Ma
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs.

Authors:  Laura A Maile; Walker H Busby; Katherine A Gollahon; William Flowers; Nikol Garbacik; Stefani Garbacik; Kara Stewart; Timothy Nichols; Dwight Bellinger; Amit Patel; Paul Dunbar; Matt Medlin; David Clemmons
Journal:  Endocrinology       Date:  2014-08-29       Impact factor: 4.736

6.  Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4.

Authors:  Ming Zhang; Chun-Mei Wang; Jing Li; Zhao-Jie Meng; Sheng-Nan Wei; Ji Li; Richard Bucala; Yu-Lin Li; Li Chen
Journal:  Mediators Inflamm       Date:  2013-12-09       Impact factor: 4.711

7.  Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.

Authors:  Guannan Yang; Zongjiang Zhao; Xinxue Zhang; Amin Wu; Yawei Huang; Yonghui Miao; Meijuan Yang
Journal:  Drug Des Devel Ther       Date:  2017-03-31       Impact factor: 4.162

Review 8.  Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities.

Authors:  Nooshin Mohammadzadeh; Soghra Mehri; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2017-05       Impact factor: 2.699

Review 9.  Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis.

Authors:  Yanwen Wang; Jeffrey A Zidichouski
Journal:  Cholesterol       Date:  2018-07-02

Review 10.  Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy.

Authors:  Guang-dong Sun; Chao-yuan Li; Wen-peng Cui; Qiao-yan Guo; Chang-qing Dong; Hong-bin Zou; Shu-jun Liu; Wen-peng Dong; Li-ning Miao
Journal:  J Diabetes Res       Date:  2015-11-15       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.